Literature DB >> 36070402

Angiotensin Receptor Blockers and Dementia Prevention: Do Not RAS to a Conclusion Yet.

Sevil Yasar1, Whitney Wharton2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 36070402      PMCID： PMC9472812          DOI： 10.1161/HYPERTENSIONAHA.122.19859

Source DB:  PubMed          Journal:  Hypertension        ISSN： 0194-911X            Impact factor:   9.897


× No keyword cloud information.
  15 in total

1.  Placebo-controlled trials of blood pressure-lowering therapies for primary prevention of dementia.

Authors:  Jan A Staessen; Lutgarde Thijs; Tom Richart; Augustine N Odili; Willem H Birkenhäger
Journal:  Hypertension       Date:  2010-12-28       Impact factor: 10.190

Review 2.  Defining the Relationship Between Hypertension, Cognitive Decline, and Dementia: a Review.

Authors:  Keenan A Walker; Melinda C Power; Rebecca F Gottesman
Journal:  Curr Hypertens Rep       Date:  2017-03       Impact factor: 5.369

3.  Angiotensin Receptor Blockers Are Associated With a Lower Risk of Progression From Mild Cognitive Impairment to Dementia.

Authors:  Zhenhong Deng; Jingru Jiang; Jia Wang; Dong Pan; Yingying Zhu; Honghong Li; Xiaoni Zhang; Xiaohuan Liu; Yongteng Xu; Yi Li; Yamei Tang
Journal:  Hypertension       Date:  2022-06-29       Impact factor: 9.897

Review 4.  Blood pressure lowering in patients without prior cerebrovascular disease for prevention of cognitive impairment and dementia.

Authors:  Bernadette McGuinness; Stephen Todd; Peter Passmore; Roger Bullock
Journal:  Cochrane Database Syst Rev       Date:  2009-10-07

5.  Alzheimer disease in the US population: prevalence estimates using the 2000 census.

Authors:  Liesi E Hebert; Paul A Scherr; Julia L Bienias; David A Bennett; Denis A Evans
Journal:  Arch Neurol       Date:  2003-08

6.  Investigation of antihypertensive class, dementia, and cognitive decline: A meta-analysis.

Authors:  Ruth Peters; Sevil Yasar; Craig S Anderson; Shea Andrews; Riitta Antikainen; Hisatomi Arima; Nigel Beckett; Joanne C Beer; Anne Suzanne Bertens; Andrew Booth; Martin van Boxtel; Carol Brayne; Henry Brodaty; Michelle C Carlson; John Chalmers; Maria Corrada; Steven DeKosky; Carol Derby; Roger A Dixon; Françoise Forette; Mary Ganguli; Willem A van Gool; Antonio Guaita; Ann M Hever; David B Hogan; Carol Jagger; Mindy Katz; Claudia Kawas; Patrick G Kehoe; Sirkka Keinanen-Kiukaanniemi; Rose Ann Kenny; Sebastian Köhler; Setor K Kunutsor; Jari Laukkanen; Colleen Maxwell; G Peggy McFall; Tessa van Middelaar; Eric P Moll van Charante; Tze-Pin Ng; Jean Peters; Iris Rawtaer; Edo Richard; Kenneth Rockwood; Lina Rydén; Perminder S Sachdev; Ingmar Skoog; Johan Skoog; Jan A Staessen; Blossom C M Stephan; Sylvain Sebert; Lutgarde Thijs; Stella Trompet; Phillip J Tully; Christophe Tzourio; Roberta Vaccaro; Eeva Vaaramo; Erin Walsh; Jane Warwick; Kaarin J Anstey
Journal:  Neurology       Date:  2019-12-11       Impact factor: 9.910

7.  Neurofibrillary Tangles and Conversion to Mild Cognitive Impairment with Certain Antihypertensives.

Authors:  Whitney Wharton; Liping Zhao; Kyle Steenland; Felicia C Goldstein; Julie A Schneider; Lisa L Barnes; Marla Gearing; Sevil Yasar
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

Review 8.  The Coming of Age of the Angiotensin Hypothesis in Alzheimer's Disease: Progress Toward Disease Prevention and Treatment?

Authors:  Patrick Gavin Kehoe
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

Review 9.  Hypertension and the Risk of Dementia.

Authors:  Cristina Sierra
Journal:  Front Cardiovasc Med       Date:  2020-01-31

10.  Effects of Candesartan vs Lisinopril on Neurocognitive Function in Older Adults With Executive Mild Cognitive Impairment: A Randomized Clinical Trial.

Authors:  Ihab Hajjar; Maureen Okafor; Darius McDaniel; Malik Obideen; Elizabeth Dee; Mahsa Shokouhi; Arshed A Quyyumi; Allan Levey; Felicia Goldstein
Journal:  JAMA Netw Open       Date:  2020-08-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.